Literature DB >> 26622454

Primary hepatic sarcomatoid carcinoma: A case report.

Qianying Leng1, X I Xiang2, Yuanjiao Tang2, Yujia Yang2, L I Qiu2.   

Abstract

Sarcomatoid carcinoma (SC) is a malignant tumor type of unclear pathogenesis, which rarely occurs in the liver. The present study reports the case of a 60-year-old woman who presented with multiple masses in her liver, with no fever, abdominal pain or jaundice. Serological markers for hepatitis B and C virus were negative, as was the test for α fetoprotein. Abdominal enhanced magnetic resonance imaging examination confirmed multiple lesions in the liver, and liquefactive necrosis was observed. The patient underwent a right hepatectomy, in addition to a cholecystectomy. Cytokeratin 8 (CK8), cluster of differentiation 117, pancytokeratin and vimentin were positively detected using immunohistochemistry, and thus the diagnosis of primary hepatic SC (PHSC) was established. During the follow-up period, characteristic imaging manifestations of tumor recurrence were detected, including peripheral enhancement, central necrosis, variable enhancement, venous invasion and intrahepatic metastasis. The immunohistochemical detection of CK, epithelial membrane antigen and vimentin, with CK8 as a critical indicator, may be useful for the diagnosis of PHSC. The preferred treatment for PHSC is surgical resection and the prognosis is poor.

Entities:  

Keywords:  primary hepatic sarcomatoid carcinoma; sarcomatoid carcinoma

Year:  2015        PMID: 26622454      PMCID: PMC4533145          DOI: 10.3892/etm.2015.2599

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  21 in total

1.  Hepatocellular carcinoma with sarcomatous change: prompt and fatal intraabdominal recurrence after liver transplantation.

Authors:  D Da Ines; A Bailly; V Lannareix; V Petitcolin; L Boldor; C Charpy; A Abergel; D Pezet; J-M Garcier
Journal:  Gastroenterol Clin Biol       Date:  2009-05-28

2.  Synovial sarcoma arising in the vulva cytogenetically confirmed by SYT break-apart rearrangement fluorescence in situ hybridization: A case report and discussion of diagnostic methods.

Authors:  Shigeto Kawauchi; Koichiro Ihara; Kei Nishikawa; Norihiro Sugino; Mutsuo Takahashi; Kohsuke Sasaki1
Journal:  Oncol Lett       Date:  2012-08-08       Impact factor: 2.967

3.  Comparative ultrastructural analysis and KIT/PDGFRA genotype in 125 gastrointestinal stromal tumors.

Authors:  Narasimhan P Agaram; Ann Baren; Knarik Arkun; Ronald P Dematteo; Peter Besmer; Cristina R Antonescu
Journal:  Ultrastruct Pathol       Date:  2006 Nov-Dec       Impact factor: 1.094

4.  Clinicopathological characteristics and outcome of primary sarcomatoid carcinoma and carcinosarcoma of the liver.

Authors:  Qi-Bo Wang; Bo-Kang Cui; Jian-Ming Weng; Qiu-Liang Wu; Ji-Liang Qiu; Xiao-Jun Lin
Journal:  J Gastrointest Surg       Date:  2012-07-06       Impact factor: 3.452

5.  Combined hepatocellular/cholangiocellular carcinoma with sarcomatoid features: genetic analysis for histogenesis.

Authors:  Masaru Murata; Yasuo Miyoshi; Kyoko Iwao; Hisashi Wada; Kunitaka Shibata; Hideo Tateishi; Takashi Shimano; Masahiko Ohasawa; Yasuharu Imai; Masahiro Nishikawa; Tetsuro Kobayashi; Yusuke Nakamura
Journal:  Hepatol Res       Date:  2001-11       Impact factor: 4.288

6.  Combined hepatocellular carcinoma and neuroendocrine carcinoma with sarcomatous change of the liver after transarterial chemoembolization.

Authors:  Chikashi Nakanishi; Koichiro Sato; Yasushi Ito; Takayuki Abe; Tetsuya Akada; Ryo Muto; Keita Sakashita; Takuro Konno; Hirotaka Kato; Susumu Satomi
Journal:  Hepatol Res       Date:  2012-11       Impact factor: 4.288

Review 7.  Spindle cell carcinoma of the intrahepatic bile duct in a patient with primary sclerosing cholangitis.

Authors:  Masahiro Shinoda; Motohide Shimazu; Makio Mukai; Minoru Tanabe; Naoko Hashiguchi; Masaya Oda; Masaki Kitajima
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

8.  Immunohistochemical distinction of cutaneous spindle cell carcinoma.

Authors:  Michael B Morgan; Chetna Purohit; Tiffany R Anglin
Journal:  Am J Dermatopathol       Date:  2008-06       Impact factor: 1.533

9.  Spindle cell hepatocellular carcinoma. A clinicopathologic and immunohistochemical analysis of 15 cases.

Authors:  T Maeda; E Adachi; K Kajiyama; K Takenaka; K Sugimachi; M Tsuneyoshi
Journal:  Cancer       Date:  1996-01-01       Impact factor: 6.860

10.  Mucinous tubular and spindle cell carcinoma of the kidney: a case report.

Authors:  Dimosthenis Chrysikos; Flora Zagouri; Theodoros N Sergentanis; Nikolaos Goutas; Dimitrios Vlachodimitropoulos; Ioannis Flessas; George Theodoropoulos; Maria Lymperi; Kostantinos Birbas; George C Zografos; Theodoros Mariolis-Sapsakos
Journal:  Case Rep Oncol       Date:  2012-07-03
View more
  3 in total

1.  Sarcomatoid carcinoma of the common bile duct: A case report.

Authors:  Shuisheng Zhang; Jia Jia; Xiaoning Bi; Qinglong Jiang; Yajie Zhao; Yingtai Chen; Quan Xu; Zhongmin Lan; Jianwei Zhang; Zhihui Zhang; Chengfeng Wang
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

2.  Characterization of a new murine cell line of sarcomatoid hepatocellular carcinoma and its application for biomarker/therapy development.

Authors:  Chia-Hung Yen; Chih-Chung Lai; Chen-Chung Liao; Sheng-Fan Wang; Yi-Jen Liao; Chien-Yi Tung; Jung-Hsien Hung; Shiu-Feng Huang; Yi-Ming Arthur Chen
Journal:  Sci Rep       Date:  2017-06-08       Impact factor: 4.379

3.  Dynamic contrast-enhanced MR and PET/CT findings of uterine sarcomatoid carcinoma: a case report.

Authors:  Tingting Cui; Yanfang Jin; Bin Li; Jiyuan Li; Yunlong Yue
Journal:  BMC Womens Health       Date:  2020-10-06       Impact factor: 2.809

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.